ACORDA THERAPEUTICS ACOR (NASDAQ)

$ 16.41
23:00
Sponsored by
Click here!
Change: -0.87 (-5.03%)
Volume: 766,000

Avg. Volume: 875355
P/E Ratio: 0
EPS (Annual): -1.90
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 32,660
Institutional Shareholders: 94.86%
Last: 16.41
Change: -0.87 (-5.03%)
Prev. Close: 17.28
Open: 16.79
Day's Range: 14.91 - 17.13
52wk Range: 14.91 - 35.65
Market Value: 640,020
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -17.91%
Total Return Last 3 Years: +48.47%
Total Return Last 5 Years: +144.20%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on ACOR
Alert me Subscribe

Earnings roundup: Molson Coors, Adidas

Among the earnings stories for Tuesday, Aug. 5, from AP Financial News: Top stories:READ MORE
Aug 05, 2008 10:41AM
Keywords: WTI, ACOR

Acorda 2Q loss grows on selling and research costs

(HAWTHORNE, N.Y.)Acorda Therapeutics Inc. said Tuesday its second-quarter loss more than doubled as it conducted a trial of a multiple sclerosis drug candidate, and stepped up sales efforts for its...READ MORE
Aug 05, 2008 7:27AM
Keywords: ACOR

Acorda Therapeutics falls following downgrade

(NEW YORK)A Friedman Billings Ramsey analyst thinks shares of Acorda Therapeutics will stay around their current prices until early next year, when the company asks regulators to approve its...READ MORE
Jun 23, 2008 11:05AM
Keywords: ACOR

Premarket roundup: Progressive, ImClone

Among the premarket stories for Monday, June 2, from AP Financial News: NEW YORK (AP)--A Friedman Billings Ramsey analyst expects larger profits for Progressive as Americans cut ba...READ MORE
Jun 02, 2008 9:42AM
Keywords: IMCL, WB, ACOR, PGR, YGE

Acorda shares soar on positive drug results

(HAWTHORNE, N.Y.)Shares of Acorda Therapeutics Inc. soared in premarket trading Monday after the biotechnology company said its multiple sclerosis drug candidate Fampridine-SR met its goal in a lat...READ MORE
Jun 02, 2008 9:17AM
Keywords: ACOR

Premarket Movers: Wachovia sinks on CEO ouster

(NEW YORK)Shares of Wachovia Corp. fell in premarket trading Monday after its board of directors asked Chief Executive Ken Thompson to retire. Thompson has been under fire from shareholders ...READ MORE
Jun 02, 2008 8:57AM
Keywords: WB, IMCL, DNA, ACOR

Acorda Therapeutics CEO exercises options

(NEW YORK)The president and chief executive of biopharmaceutical company Acorda Therapeutics Inc. exercised options for 31,432 shares of common stock under a prearranged trading plan, accord...READ MORE
May 13, 2008 4:24PM
Keywords: ACOR
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN -15.10 48.58
GILEAD SCIENCES -26.60 37.47
GENENTECH INC -9.90 73.00
CELGENE CP -26.70 54.52
BIOGEN IDEC INC -34.90 42.78